“…The patient and her parents had been tested before, for the following 10 short-tandem-repeat polymorphism (STRP) markers from the 22q11.2 region: D22S264 (Marineau et al 1992); D22S311 and D22S306 (Porter et al 1993); D22S427 (Gyapay et al 1994); D22S941 and D22S944 (Morrow et al 1995); and D22S1638, D22S1648, D22S1623, and D22S308 (Carlson et al 1997a, Genome Database), as described elsewhere (Rauch et al 1998b). Subsequently, the patient, her sibs, her parents, and her maternal grandparents were tested for STRPs at the loci D22S311 (Genome Database 190609), D22S1709 (Genome Database 5865052), D22S306 (Genome Database 190620), D22S308 (Genome Database 190623), D22S425 (Genome Database 199610), D22S303 (Genome Database 190616), D22S257 (Genome Database 180549), D22S301 (Genome Database 190613), D22S156 (Genome Database 177327), TOP1P2 (Genome Database 159908), D22S1144 (Genome Database 606049; SangerCentre bK929C8), and D22S1167 (Genome Database 610902; Sanger Centre bK373H7), by PCR amplification of DNA extracted from fresh peripheral blood and separation on 6% denaturing polyacrylamide gels (41 cm) in a Li-cor (MWG-Biotech) sequencer, as described elsewhere (Rauch et al 1998b).…”